Literature DB >> 10911509

Turmeric.

K L Grant1, C D Schneider.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10911509

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  5 in total

1.  Curcumin prevents human dendritic cell response to immune stimulants.

Authors:  Shawna A Shirley; Alison J Montpetit; R F Lockey; Shyam S Mohapatra
Journal:  Biochem Biophys Res Commun       Date:  2008-07-17       Impact factor: 3.575

2.  Curcumin: A Contact Allergen.

Authors:  Soham P Chaudhari; Alison Y Tam; Jason A Barr
Journal:  J Clin Aesthet Dermatol       Date:  2015-11

3.  Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial.

Authors:  Shanu Kohli Kurd; Nana Smith; Abby VanVoorhees; Andrea B Troxel; Vladimir Badmaev; John T Seykora; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2008-02-04       Impact factor: 11.527

Review 4.  Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.

Authors:  Chung-Pu Wu; Shinobu Ohnuma; Suresh V Ambudkar
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

5.  Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris.

Authors:  Emiliano Antiga; Veronica Bonciolini; Walter Volpi; Elena Del Bianco; Marzia Caproni
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.